tech

View from DLA Piper

Digital Therapeutics – Evolution and entry into mainstream healthcare

Research undertaken by DLA Piper’s Life Sciences practice in conjunction with The Lawyer seeks to understand the current developments in the field of digital therapeutics, looking at key questions that need to be addressed if these products are to become mainstream components of health systems across the world.